Otrivelle (Choriogonadotropin Alfa 250mcg/0.5ml)

Fertility Treatment and Hormonal Support

🧬 What is Otrivelle?

Otrivelle is an injectable solution containing Choriogonadotropin Alfa, a hormonal treatment used primarily for fertility purposes. Each pre-filled syringe contains 250 micrograms of Choriogonadotropin Alfa, which is equivalent to approximately 6,500 IU of human chorionic gonadotropin (hCG), a hormone essential in regulating ovulation and testicular function.

Used mainly for stimulating ovulation in women undergoing fertility treatments, Otrivelle supports egg maturation and follicular growth, increasing the chances of successful conception. It is also used in some male infertility treatments to stimulate sperm production in men with low testosterone levels.

⚙️ Key Benefits of Otrivelle

• 🏠 Ovulation induction – Helps stimulate egg maturation and ovulation for women undergoing fertility treatments

• 🧑‍⚕️ Male infertility treatment – Stimulates testosterone production and sperm development in men with fertility issues

• 💪 Increased chances of conception – Boosts fertility treatment outcomes, particularly in in vitro fertilization (IVF)

• 🌱 Pre-filled syringe for convenience – Ready-to-use injection solution, ensuring accurate dosage and ease of use

• 🌍 Globally trusted – Choriogonadotropin Alfa is widely used in fertility clinics and for hormonal therapy worldwide

📋 Recommended Dosage

• Standard Dosage for Women: 250 mcg (1 pre-filled syringe) once, typically administered subcutaneously or intramuscularly

• Male Dosage: Dependent on the physician’s recommendation, generally for men with low testosterone levels to stimulate sperm production

• Administration: Injectable solution for subcutaneous or intramuscular injection

• Timing: Typically used before ovulation in fertility treatments or as directed by a healthcare provider

• Note: Always follow doctor’s instructions for precise dosage and cycle management.

⚠️ Side Effects and Considerations

While Otrivelle is generally safe when used under medical supervision, some individuals may experience mild side effects, including:

• Injection site reactions – Mild pain, redness, or swelling at the injection site

• Ovarian hyperstimulation syndrome (OHSS) – In rare cases, excessive stimulation of ovaries can lead to swollen ovaries, fluid retention, or discomfort

• Mood changes – Hormonal fluctuations may cause mood swings or irritability

• Headaches – Some users may experience headaches as a side effect

• Abdominal discomfort – Bloating or pain may occur in some women, particularly during ovulation stimulation

💡 Tip: Always follow your healthcare provider’s guidelines and report any severe reactions immediately.

🧪 Product Specifications

• Active Ingredient: Choriogonadotropin Alfa

• Strength: 250 mcg per pre-filled syringe (approximately 6,500 IU)

• Pack Size: 1 pre-filled syringe (0.5 ml)

• Form: Injectable solution

• Indications: Ovulation induction, male infertility, and testosterone production stimulation

• Manufacturer: [Brand Name]

• Storage: Store in the refrigerator (2°C–8°C). Do not freeze.

💡 Final Word

Otrivelle (Choriogonadotropin Alfa) is a trusted and effective solution for fertility treatments, offering a reliable method to stimulate ovulation in women and testosterone production in men with low fertility. With its pre-filled syringe and accurate dosage, it provides a convenient and safe option for individuals seeking to improve fertility outcomes.

Consult with a healthcare provider to ensure proper dosage, administration, and cycle management for the best results.